Search

Search Constraints

You searched for: Author/Creator Stoops, Erik

Search Results

21. Cerebrospinal fluid tau biomarkers in the prediction and concordance of neurofibrillary tangle and amyloid pathology: Biomarkers (non‐neuroimaging): Longitudinal and prognostic biomarker studies. (7th December 2020)

22. Comparison of two analytical platforms for blood‐based surrogate biomarkers of amyloid pathology: Biomarkers (non‐neuroimaging) / plasma/serum/urine biomarkers. (7th December 2020)

24. Development and analytical characterization of novel tau Simoa assays targeting full‐length tau in CSF and mid‐tau in CSF and plasma. (31st December 2021)

26. Development of an ultrasensitive multiplex assay for simultaneous detection of Aβ1‐42, Aβ1‐40, GFAP and NF‐L in blood: Biomarkers (non‐neuroimaging) / plasma/serum/urine biomarkers. (7th December 2020)

27. Differential diagnostic performance of a panel of plasma biomarkers for different types of dementia. Issue 1 (15th May 2022)

28. Distinctive effect of biological sex in AD‐related CSF and plasma biomarkers. (31st December 2021)

29. F1‐05‐01: LAB‐RELATED PRE‐ANALYTICAL FACTORS INFLUENCING PLASMA AMYLOID BETA CONCENTRATIONS. (1st July 2019)

30. F2‐07‐04: PLASMA AMYLOID BETA 1–42 AND 1–40 MEASURED BY A NOVEL SIMOA ASSAY AS A DIAGNOSTIC TOOL FOR ALZHEIMER'S DISEASE PATHOLOGY. (1st July 2019)